Description
AGDV is a C-terminal peptide sequence found on fibrinogen that is known as a binding site for glycoprotein IIb/IIIa (integrin αIIbβ3); this binding is required for platelet adhesion and aggregation.
AGDV is a C-terminal peptide sequence found on fibrinogen that is known as a binding site for glycoprotein IIb/IIIa (integrin αIIbβ3); this binding is required for platelet adhesion and aggregation.
| Purity | ≥95% |
|---|---|
| Formula | C14H24N4O7 |
| Formula Wt. | 360.37 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Srokowski EM, Woodhouse KA. Evaluation of the bulk platelet response and fibrinogen interaction to elastin-like polypeptide coatings. J Biomed Mater Res A. 2014 Feb;102(2):540-51. PMID: 23505204.
Podolnikova NP, Gorkun OV, Loreth RM, et al. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa). Biochemistry. 2005 Dec 27;44(51):16920-30. PMID: 16363805.
Liu Q, Rooney MM, Kasirer-Friede A, et al. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads. Biochim Biophys Acta. 1998 Jun 11;1385(1):33-42. PMID: 9630497.
CRTH2 inhibitor, TxA2 antagonist.
Triterpene saponin found in species of Panax.
Prodrug
Mycotoxin contaminant found in cereal grains.
NSAID; COX-1/2 inhibitor.
Alpha blocker and vasoactive agent.
Steroid; glucocorticoid agonist.
B-Raf and c-Raf inhibitor.
Purine nucleoside analog; DNA chain terminator,...
Synthetic progestogen, orexigenic.
NSAID; COX-1/2 inhibitor.
Glutathione-sulforaphane conjugate, antioxidant...
Peptide, confers resistance against macrolide a...
Pyrimidine nucleoside (cytidine) analog; DNA ch...
Phase II enzyme inducer; Nrf2 activator; antiox...
Steroid hormone, contraceptive; PR agonist.
Resveratrol prodrug; potential SIRT1 activator....
SV2A synaptic vesicle inhibitor.